- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00306358
Plasma Holotranscobalamin as Compared to Plasma Cobalamins for Assessment of Vitamin B12 Absorption
Plasma Holotranscobalamin as Compared to Plasma Cobalamins for Assessment of Vitamin B12 Absorption. Optimisation of a Non-Radioactive Vitamin B12 Absorption Test (CobaSorb)
In the present study the design of the vitamin B12 absorption test, CobaSorb, is further optimised. We investigate which test - measurement of holotranscobalamin or cobalamins - could be used for reflection of vitamin B12 absorption. Furthermore, we prolong the duration of vitamin B12 administration in order to determine the final duration of the vitamin B12 absorption test CobaSorb.
Seventy-eight healthy individuals (age 21-81 years) are treated with three oral doses of 9 microgram cyanocobalamin per day for five successive days. Non-fasting blood samples are collected on day 1-5 before administration of the first dose of vitamin B12 and on day 8. Cobalamins and holotranscobalamin are measured on day 1-5 and 8. The performance of the vitamin B12 absorption test will be evaluated in individuals with borderline or low levels of holotranscobalamin or cobalamins (below the 75% percentiles) using a change larger than 2CV(day to day) of holotranscobalamin (22%) and cobalamins (12%) to indicate a change caused by absorption of the administered vitamin B12.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In the present study the design of the vitamin B12 absorption test, CobaSorb, is further optimised. We investigate which test - measurement of holotranscobalamin or cobalamins - could be used for reflection of vitamin B12 absorption. Furthermore, we prolong the duration of vitamin B12 administration in order to determine the final duration of the vitamin B12 absorption test CobaSorb.
Seventy-eight healthy individuals (age 21-81 years) are treated with three oral doses of 9 microgram cyanocobalamin per day for five successive days. Non-fasting blood samples are collected on day 1-5 before administration of the first dose of vitamin B12 and on day 8. Cobalamins and holotranscobalamin are measured on day 1-5 and 8. The performance of the vitamin B12 absorption test will be evaluated in individuals with borderline or low levels of holotranscobalamin or cobalamins (below the 75% percentiles) using a change larger than 2CV(day to day) of holotranscobalamin (22%) and cobalamins (12%) to indicate a change caused by absorption of the administered vitamin B12.
Study Type
Enrollment
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aarhus, Denmark, 8000
- Aarhus Sygehus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Above 18 years North european origin Read and understand Danish
Exclusion Criteria:
Vitamin B12 treatment within the past 5 years Use of vitamin pills containing >1 microgram vitamin B12 with in the past 3 weeks Infectious disease Pregnancy Lactation Giving birth within the past 9 months Use of hormones Known systemic disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Changes in plasma holotranscobalamin after intake of vitamin B12
|
Secondary Outcome Measures
Outcome Measure |
---|
Changes in plasma cobalamins, plasma methylmalonic acid and plasma homocysteine after intake of vitamin B12.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Anne-Mette Hvas, Cand Med PhD, Dept. of Clinical Biochemistry, Skejby Sygehus, 8000 Aarhus, Denmark
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20050067
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitamin B12 Absorption
-
University of HelsinkiNot yet recruiting
-
University of FloridaNational Center for Research Resources (NCRR)CompletedDisorder of Vitamin B12United States
-
Church & Dwight Company, Inc.Medical University of South CarolinaCompletedMeasure Absorption of Vitamin D in BloodUnited States
-
Charite University, Berlin, GermanyCompletedDeficiency, Vitamin | Vegan's Anemia (Vitamin B12 Deficiency) | Deficiencies MicronutrientGermany
-
USDA, Western Human Nutrition Research CenterCompletedBioavailability of Vitamin B12 From Chicken EggsUnited States
-
Texas A&M UniversityUnknownCognitive Change | Nutritional Anemia | Diet, Healthy | Nutrient Deficiency | Diet; Deficiency | Visual Spatial Processing | Dietary Deficiency | Dietary B12 Deficiency | Dietary Zinc Deficiency | Dietary Vitamin B12 Deficiency Anemia | Dietary Deficiency of Selenium and Vitamin EUnited States
-
James J. Peters Veterans Affairs Medical CenterCompletedMacrocytic Anemia With Vitamin B12 DeficiencyUnited States
-
University Children's Hospital, ZurichActive, not recruitingVitamin B 12 DeficiencyAustria, Germany
-
University of British ColumbiaDairy Farmers of CanadaCompletedVitamin B 12 DeficiencyCanada
-
Haukeland University HospitalNorwegian Foundation for Health and Rehabilitation; Foundation to Promote Research...CompletedVitamin B 12 DeficiencyNorway
Clinical Trials on Vitamin B12 (Cyanocobalamin)
-
Haukeland University HospitalThe Research Council of Norway; The Royal Norwegian Ministry of Health; Norwegian... and other collaboratorsCompletedMyocardial Infarction | Coronary Artery Disease | Cerebrovascular StrokeNorway
-
University of AarhusCompleted
-
Northwell HealthStaten Island University HospitalCompletedVitamin B12 DeficiencyUnited States
-
Sykehuset Innlandet HFUniversity of Oslo; University of Bergen; Inland Norway University of Applied...Recruiting
-
Emisphere Technologies, Inc.Completed
-
Emisphere Technologies, Inc.CompletedVitamin B 12 Deficiency
-
The University of Texas Health Science Center,...Active, not recruitingGlucose Intolerance | Drug Effect | Overweight and Obesity | AdiposityUnited States
-
Ali AltunkayaNational Cancer Institute (NCI)TerminatedBrain and Central Nervous System Tumors | Cerebral EdemaUnited States
-
University of Southern CaliforniaCompleted
-
Swedish Orphan BiovitrumCompletedFocus: BioavailabilitySweden